Unique ID issued by UMIN | UMIN000040609 |
---|---|
Receipt number | R000046278 |
Scientific Title | Relationship between sofosbuvir + velpatasvir + ribavirin combination therapy and drug resistance mutation for DAA treatment failure cases |
Date of disclosure of the study information | 2020/06/01 |
Last modified on | 2020/06/01 13:23:23 |
Relationship between sofosbuvir + velpatasvir + ribavirin combination therapy and drug resistance mutation for DAA treatment failure cases
Relationship between sofosbuvir + velpatasvir + ribavirin combination therapy and drug resistance mutation for DAA treatment failure cases
Relationship between sofosbuvir + velpatasvir + ribavirin combination therapy and drug resistance mutation for DAA treatment failure cases
Relationship between sofosbuvir + velpatasvir + ribavirin combination therapy and drug resistance mutation for DAA treatment failure cases
Japan |
Chronic hepatitis C
Hepato-biliary-pancreatic medicine |
Others
YES
We plan to collect clinical data of patients who are treated with sofosbuvir + velpatasvir + ribavirin at our hospital and clarify the actual condition of the treatment.
Safety,Efficacy
The significance of this study is to collect clinical data on treatment and to clarify the association with drug resistance mutations.
Observational
20 | years-old | <= |
Not applicable |
Male and Female
Patients over 20 years old
Patients who cannot regularly visit the outpatient department of hepatobiliary-pancreatic medicine.
Patients with hepatocellular carcinoma.
Patients with impaired renal function (eGFR 30 ml / min / less than 1.73 m2).
Patients who are allergic to this drug.
Patients who are taking contraindications for this study drugs.
Patients who are judged by the attending physician to possibly impair patient safety.
12
1st name | Akihiro |
Middle name | |
Last name | Tamori |
School of Medicine and Graduate school of Medicine Osaka City University
Department of Hepatology
545-8585
1-4-3, Asahimachi, Abeno, Osaka 545-8585, JAPAN
06-6645-3905
atamori@med.osaka-cu.ac.jp
1st name | Akihiro |
Middle name | |
Last name | Tamori |
School of Medicine and Graduate school of Medicine Osaka City University
Department of Hepatology
545-8585
1-4-3, Asahimachi, Abeno, Osaka 545-8585, JAPAN
06-6645-3905
atamori@med.osaka-cu.ac.jp
School of Medicine and Graduate school of Medicine Osaka City University
School of Medicine and Graduate school of Medicine Osaka City University
Other
School of Medicine and Graduate school of Medicine Osaka City University
1-4-3, Asahimachi, Abeno, Osaka 545-8585, JAPAN
06-6645-3456
ethics@med.osaka-cu.ac.jp
NO
2020 | Year | 06 | Month | 01 | Day |
Unpublished
Open public recruiting
2019 | Year | 01 | Month | 28 | Day |
2019 | Year | 04 | Month | 25 | Day |
2019 | Year | 02 | Month | 01 | Day |
2026 | Year | 03 | Month | 31 | Day |
To confirm the efficacy and safety of patients who have received this treatment.
2020 | Year | 06 | Month | 01 | Day |
2020 | Year | 06 | Month | 01 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046278
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |